|
|
|
 | A Revolution in Data Gathering: John Wilbanks Guest: John Wilbanks, Senior Fellow , The Kauffman Foundation Bio and Contact Info Listen (7:31) Disconnect between informed consent and digital technology Listen (9:26) Consent to Research Project Listen (5:59) Who will be the early volunteers to share their data? Listen (11:46) Access2Research petition at White House-now what? Listen (3:59) Can you describe the nature of the legal threats you've received? Listen (3:33) Would you donate your child's data to research? Listen (4:23) Data gathering undergoing a revolution "I like making it easier to share things," says John Wilbanks, a senior fellow at the Kauffman Foundation. Also a member of the Board of Directors for Sage Bionetworks, Wilbanks has been involved in numerous projects having to do with opening up important content and data. Now he runs the Consent to Research Project where he is designing systems that allow people to donate their research to data. Wilbanks discusses the disconnect that is emerging between informed consent and the realities of the digital revolution. In this comprehensive interview he talks about the Access2Research petition he recently spearheaded to extend the NIH's open access policy to the other federal agencies. Why does John like making it easier to share things? Hear about his past and find out his thoughts on data gathering in the future. |  | Exclusive podcast with Mark Mathieu The PAREXEL Biopharmaceutical R&D Statistical Sourcebook is the industry’s leading resource for statistics, trends, and proprietary market intelligence and analysis on the biopharmaceutical industry. Supported by thousands of graphs, illustrations, and analyses, the Sourcebook provides the latest intelligence on every aspect of biopharmaceutical development – from product discovery, to R&D performance and productivity, to time-to-market analysis. Mark Mathieu is the Editor of the Sourcebook, and director of strategic research at PAREXEL Consulting. In this interview, he discusses the emerging metrics and benchmarks on the current state and direction of today’s biopharm industry, industry activity in clinical development, metrics by therapeutic area, and clinical trials in emerging markets. |  | Open Flow Tackles Network Automation and Programmability for Cloud Implementations Speaker: Isabelle Guis, Vice President, Outbound Marketing, Big Switch Networks
Learn more about this topic at the Bio-IT Cloud Summit, September 11-13, 2012 in San Francisco | | Folding in The Cloud Distributed Computing Project Interview with: Vijay Pande, Ph.D., Professor, Chemistry, Structural Biology, Computer Science; Director, Biophysics Program; Director, Folding@home Learn more about this topic at the Bio-IT Cloud Summit, September 11-13, 2012 in San Francisco | | Life in the Fast Lane - Genomes Race to the Cloud Interviews with:
Michael Sullivan, M.D., Associate Director, Health Sciences, Internet2
Stephen Simms, Manager, High Performance File Systems, Indiana University Pervasive Technology Institute
Learn more about this topic at the Bio-IT Cloud Summit, September 11-13, 2012 in San Francisco |  | Challenges Inherent in Designing and Analyzing Experiments Using NGS Speaker: Ghia Euskirchen, Ph.D., Director of DNA Sequencing Program, Center for Genomics & Personalized Medicine, Stanford University School of Medicine |
|
|
|